Eyestem

Eyestem is a biotech company in Bengaluru, India, founded in 2015. It has 1 recorded funding round, most recently a Venture Round in January 2021.

Developing scalable cell replacement therapies for the world

Headquarters
Bengaluru
Employees
11–50
Founded
2015
Business Model
B2B
Last Round
Venture RoundJan 2021
Rounds
1

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Eyestem is a clinical-stage cell therapy company founded in January 2015 by Dr. Jogin Desai, Dr. Rajani Battu, Dr. Rajarshi Pal, and Dr. Dhruv Sareen, headquartered in Bangalore, India. The company is building a scalable, allogeneic cell-replacement therapy platform to treat previously incurable diseases, with embedded manufacturing and quality processes designed to lower the cost and time-to-market for cell therapies. Its lead product, Eyecyte-RPE, targets Dry Age-related Macular Degeneration (AMD), the largest cause of incurable blindness in people over 60, and is currently in Phase 2 clinical trials after a Phase 1 study in nine subjects showed the treatment was safe and well-tolerated.

Summary

It lists 11–50 employees. Its most recent funding was a Venture Round in Jan 2021. Investors include Kotak Private Equity.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Venture RoundSecond Funding RoundJan 2021

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Eyestem on Indexed.vc
<a href="https://indexed.vc/companies/eyestem"><img src="https://indexed.vc/api/badge/company/eyestem" alt="Eyestem on Indexed.vc" width="260" height="76" /></a>